These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15261228)

  • 1. A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test.
    Kim JS; Lee KS; Kim YI; Tamai Y; Nakahata R; Takami H
    J Clin Neurosci; 2004 Aug; 11(6):600-2. PubMed ID: 15261228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects.
    Aruna D; Naidu MU
    Br J Clin Pharmacol; 2007 Mar; 63(3):333-8. PubMed ID: 17010102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.
    Angiolillo DJ; Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Sumner S; Desai B; Charlton RK; Box LC; Zenni M; Guzman LA; Bass TA
    Thromb Haemost; 2011 Aug; 106(2):253-62. PubMed ID: 21614414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
    Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
    Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
    Angiolillo DJ; Capranzano P; Goto S; Aslam M; Desai B; Charlton RK; Suzuki Y; Box LC; Shoemaker SB; Zenni MM; Guzman LA; Bass TA
    Eur Heart J; 2008 Sep; 29(18):2202-11. PubMed ID: 18567918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.
    Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
    Eur J Vasc Endovasc Surg; 2009 May; 37(5):604-10. PubMed ID: 19297212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus.
    Tamai Y; Takami H; Nakahata R; Ono F; Munakata A
    Haemostasis; 1999; 29(5):269-76. PubMed ID: 10754379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination.
    Comerota AJ
    Atheroscler Suppl; 2005 Dec; 6(4):13-9. PubMed ID: 16275168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel.
    Cohen MG; Rossi JS; Garbarino J; Bowling R; Motsinger-Reif AA; Schuler C; Dupont AG; Gabriel D
    Thromb Res; 2011 Oct; 128(4):335-40. PubMed ID: 21621252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study.
    Jeong YH; Lee SW; Choi BR; Kim IS; Seo MK; Kwak CH; Hwang JY; Park SW
    J Am Coll Cardiol; 2009 Mar; 53(13):1101-9. PubMed ID: 19324253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
    Jakubowski JA; Payne CD; Li YG; Farid NA; Brandt JT; Small DS; Salazar DE; Winters KJ
    Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of the anti-platelet drugs, clopidogrel, ticlopidine, and cilostazol on aspirin-induced gastric bleeding and damage in rats.
    Takeuchi K; Takayama S; Izuhara C
    Life Sci; 2014 Aug; 110(2):77-85. PubMed ID: 24984214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery.
    Onoda K; Ohashi K; Hashimoto A; Okuda M; Shimono T; Nishikawa M; Shimpo H
    Ann Thorac Cardiovasc Surg; 2008 Aug; 14(4):230-7. PubMed ID: 18818572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial.
    Lim E; Cornelissen J; Routledge T; Kirtland S; Charman SC; Bellm S; Munday H; Khan O; Masood I; Large S
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):432-5. PubMed ID: 15354104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
    Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
    Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
    Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
    Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of two different formulations of clopidogrel bisulfate tablets on platelet aggregation and bleeding time in healthy Korean volunteers: A single-dose, randomized, open-label, 1-week, two-period, phase IV crossover study.
    Shim CY; Park S; Song JW; Lee SH; Kim JS; Chung N
    Clin Ther; 2010 Aug; 32(9):1664-73. PubMed ID: 20974324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
    De Kam PJ; Luo WL; Wenning L; Ratcliffe L; Sisk CM; Royalty J; Radziszewski W; Wagner JA; Lai E
    Platelets; 2014; 25(7):480-7. PubMed ID: 24206527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study.
    Montalescot G; Sideris G; Cohen R; Meuleman C; Bal dit Sollier C; Barthélémy O; Henry P; Lim P; Beygui F; Collet JP; Marshall D; Luo J; Petitjean H; Drouet L
    Thromb Haemost; 2010 Jan; 103(1):213-23. PubMed ID: 20062936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.